| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 06/16/2009 | US7547769 Immunomodulatory constructs and their uses |
| 06/16/2009 | US7547765 For modifying polypeptides; shikimic acid, quinic acid, or carbohydrate derivatives of polyalkylene glycols; improves bioavailability of modified peptides such as enzyme, a cytokine or a hormone e.g. interferon beta or granulocyte colony stimulating factor; biodrugs |
| 06/16/2009 | US7547762 T24 antigen for immunodiagnosis of Taenia solium cysticercosis |
| 06/16/2009 | US7547759 Stimulating cytotoxic T-lymphocytes |
| 06/16/2009 | US7547517 complexes, expression vectors and host cells transformed or transfected with nucleic acid molecules encoding MAGE-C2; for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring |
| 06/11/2009 | WO2009054878A8 Compositions and methods for the treatment of neoplasia |
| 06/11/2009 | WO2007028106A3 Host cell lines for production of antibody constant region with enhanced effector function |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | WO2001098458A3 Methods for immobilizing polypeptides |
| 06/10/2009 | EP2066697A2 Modified self-assembling peptides |
| 06/10/2009 | EP1648692A4 Cellulose matrix encapsulation and method |
| 06/10/2009 | CN100497437C Preparation method of polyethylene carboxylic acid and its use |
| 06/09/2009 | US7544773 Antimicrobials against pathogenic bacteria and method for screening them |
| 06/09/2009 | US7544770 Multilayer films, coatings, and microcapsules comprising polypeptides |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544502 Nucleotide sequences coding insecticidal for use in biological pest control; larvicides |
| 06/09/2009 | US7544496 Process for making organic/inorganic composites |
| 06/09/2009 | US7544361 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration |
| 06/09/2009 | US7544354 Methods of protein purification and recovery |
| 06/04/2009 | WO2009033095A3 Humanized pai-1 antibodies |
| 06/04/2009 | US20090142786 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2064226A2 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators |
| 06/02/2009 | US7541440 Invention provides monoclonal antibody or fragment thereof that binds granulocyte (neutrophil) antigen, preferably provides humanized, chimeric and human anti-granulocyte-targeting antibodies, such as MN3 antibodies, useful for treatment and diagnosis of malignancy diseases resulting from ischemic injury |
| 06/02/2009 | US7541438 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
| 06/02/2009 | US7541335 Nogo-receptors and methods of use |
| 06/02/2009 | US7541167 porous glass composite gel of water and polymer network made using an alkoxosilane derivative; group alterable charge, and hydrophobic and hydrophilic groups; separation media, drug delivery vehicles, and electric and mechanical actuators |
| 06/02/2009 | US7541029 Anti-rhesus D monoclonal antibodies |
| 05/28/2009 | WO2009066502A1 Solid support |
| 05/28/2009 | WO2009066454A1 Abnormal prion protein binder, and method for detection of abnormal prion protein |
| 05/28/2009 | WO2007067596A3 Methods and compositions for needleless delivery of antibodies |
| 05/28/2009 | US20090137419 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/28/2009 | CA2705871A1 Abnormal prion protein binder, and method for detection of abnormal prion protein |
| 05/27/2009 | EP2062921A1 Process for producing a carrier |
| 05/27/2009 | CN101443035A Vaccine for treatment or prophylaxis therapy of myasthenia gravis |
| 05/26/2009 | US7538192 Nucleotide sequence/polypeptide fusion for use as capture tool on solid supports during genomic analysis |
| 05/26/2009 | US7538083 Compositions and methods for the potentiation of immune responses against target antigens |
| 05/26/2009 | CA2230492C Human growth hormone variants |
| 05/26/2009 | CA2174325C Non-antigenic branched polymer conjugates |
| 05/22/2009 | WO2009064321A2 Biomarker detection |
| 05/22/2009 | WO2009062399A1 Peptide ligand directed drug delivery |
| 05/22/2009 | WO2006105479A3 Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases |
| 05/22/2009 | CA2719103A1 Biomarker detection |
| 05/21/2009 | US20090130107 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 05/20/2009 | EP2059598A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 05/20/2009 | CN101437853A Biocompatible three dimensional matrix for the immobilization of biological substances |
| 05/20/2009 | CN100488984C Reducing immunogenicity of fusion proteins |
| 05/19/2009 | US7534857 Methods and compositions for the treatment and prevention of staphylococcal infections |
| 05/19/2009 | US7534856 PRO19624 antibodies |
| 05/14/2009 | WO2009059784A1 Biocompatible three dimensional matrix for the immobilization of biological substances |
| 05/14/2009 | WO2007013949A3 Asbestos exposure, pleural mesothelioma, and serum osteopontin levels |
| 05/14/2009 | US20090123985 Method for fabricating aerogels and their application in biocomposites |
| 05/14/2009 | US20090123422 Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-y |
| 05/13/2009 | EP2058335A1 Biocompatible three dimensional matrix for the immobilization of biological substances |
| 05/13/2009 | EP1965881B1 Synthetic peptide ligands able to bind ochratoxin a and uses thereof |
| 05/13/2009 | CN100486997C Efficent polyethylene glycol activating process |
| 05/12/2009 | US7531627 Protein ACA1 of Antrodia camphorata |
| 05/12/2009 | US7531502 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells |
| 05/07/2009 | WO2009058363A1 Antibody to rage and uses for in vivo imaging or for targeting therapy |
| 05/07/2009 | WO2009058322A1 Albumin fusion proteins |
| 05/07/2009 | WO2009057901A2 Methods for immobilizing cells |
| 05/07/2009 | WO2006125202A3 Anti- mcp-1 antibodies, compositions, methods and uses |
| 05/07/2009 | WO2006094200A3 Method of obtaining a desired localization for cellular imaging with the use of peptidoconjugates |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | CA2707861A1 Glucagon antagonists |
| 05/07/2009 | CA2703943A1 Albumin fusion proteins |
| 05/06/2009 | EP2054711A1 A microarray system and a process for producing microarrays |
| 05/05/2009 | US7527946 Angiogenesis and neovascularization inhibition; host cells, recombinant DNA; increased half life and longer vasculature retention time |
| 05/05/2009 | US7527798 Composition and method for preventing or treating a virus infection |
| 05/05/2009 | CA2248247C Means for the biological purification of a biological fluid |
| 04/30/2009 | WO2009055421A1 Chimeric c3-like rho antagonist cardiac therapeutic |
| 04/30/2009 | WO2009053339A2 Cholesterol derivatives of inhibitors of viral fusion |
| 04/30/2009 | WO2009032978A3 Compositions and methods for diagnosing and treating urinary tract infections |
| 04/30/2009 | WO2009004142A3 Method for fixing compounds comprising peptide bonds, such as proteins, to a microsystem, and microsystem incorporating these compounds |
| 04/30/2009 | WO2008143731A3 Surface grafted conjugated polymers |
| 04/30/2009 | WO2008085794A3 Methods and compositions related to clot binding compounds |
| 04/30/2009 | CA2699894A1 Cholesterol derivatives of inhibitors of viral fusion |
| 04/29/2009 | EP2051734A2 Agents for blood-brain barrier delivery |
| 04/29/2009 | EP1218509B1 Fibroblast growth factor-like polypeptides |
| 04/29/2009 | CN100482684C Cytokine protein family |
| 04/28/2009 | US7524933 lyases enzymes obtained from transformed plant tissue expressing polynucleotide that encodes the polypeptide; improved ethanol biosynthesis, stalk and nodal strength |
| 04/28/2009 | US7524657 Alleles of the sigA gene from coryneform bacteria |
| 04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/28/2009 | CA2107856C Detection of antibiotics |
| 04/23/2009 | WO2009020459A3 Glucanases, nucleic acids encoding them and methods for making and using them |
| 04/23/2009 | WO2007055966A3 Therapies for cancer using rlip76 |
| 04/23/2009 | WO2007046893A3 Methods for generating bioactive assemblies and uses thereof |
| 04/23/2009 | WO2006133333A3 Stimulation of pancreatic b cell proliferation |
| 04/23/2009 | WO2006076467A3 Treatment of pre-eclampsia in pregnant women using targeted apheresis |
| 04/22/2009 | EP2049669A2 Spore surface displays of bioactive molecules |
| 04/22/2009 | EP1587476A4 Novel compositions and methods in cancer |
| 04/22/2009 | CN100480274C Hydroxyalkyl starch derivatives |
| 04/22/2009 | CN100480266C Interferon-beta fusion proteins and uses |
| 04/21/2009 | US7521539 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferation disorders |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521262 Functionalized silicon surfaces |
| 04/21/2009 | US7521235 Unique novel Bacillus thuringiensis gene with Lepidopteran activity |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008039483A9 Modified self-assembling peptides |
| 04/16/2009 | WO2006138449A3 Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen |